一种具有向单片氧释放和同时发出光信号的静止性内氧化剂
Shoucai Yan1, Yu Si1, Xiao Qian1
1State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, Dalian University of Technology, 116024, Dalian, P. R. China. leiwang@dlut.edu.cn.
Journal of materials chemistry. B
|February 10, 2026
概括
研究人员开发了一种用于光动力学治疗的新型纳夫他林内氧化物,改善单片氧释放,用于增强癌症治疗. 一个新的成像系统允许实时监测瘤中的治疗激活.
科学领域:
- 药用化学 医学化学
- 光动力学疗法 光动力学疗法
- 癌症治疗方法 癌症治疗方法
背景情况:
- 光动力疗法 (PDT) 面临的局限性包括短单片氧 (1O2) 释放时间.
- 开发具有受控O2生成的新型光敏感剂对于提高PDT疗效至关重要.
- 瘤微环境往往表现出过高的过氧化 (H2O2) 水平,为向治疗提供了机会.
研究的目的:
- 设计和合成一种新型的乙烯衍生的内氧化物,具有优化的O2释放动力学,用于增强PDT.
- 研究O2生成的机制,并评估该化合物的细胞毒性和体内疗效.
- 开发一种基于瘤特定H2O2水平的治疗激活实时监测的治疗系统.
主要方法:
- 1,4-二甲基纳二烯的结构优化,以创建具有胺基组的新型内氧化物.
- 评估O2释放半衰期 (t1/2) 和通过热循环逆转的机制.
- 在体外细胞毒性测定 (IC50) 和使用小鼠4T1乳腺癌模型的体内研究.
- 模块化纳夫他胺基光探针的设计,通过乙烯 Ester 连接响应H2O2.
主要成果:
- 优化的内氧化物表现出延长的O2释放半衰期 (8.6小时),促进持续的O2输送到瘤.
- 该化合物通过热循环逆转诱导的O2生成,对癌细胞系表现出强烈的细胞毒性 (IC50 = 11.6 μM).
- 在体内观察到显著的瘤抑制,在治疗剂量时没有全身毒性.
- 响应H2O2的探头成功检测到癌细胞中H2O2的升高,触发了光从蓝色到绿色的转变,证实了治疗激活.
结论:
- 新型纳夫他林内氧化物代表了PDT的有希望的光敏化剂,可以改善1O2释放的时间控制.
- 开发的治疗系统允许在瘤微环境中视觉确认PDT激活,从而可以实时评估疗效.
- 这种方法提供了一个潜在的策略,可以通过综合监测能力来实现更有效和更有针对性的癌症治疗.
相关概念视频
What is Cell Signaling?
131.1K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.1K
Endocrine Signaling
68.2K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.2K
Energy-releasing Steps of Glycolysis
147.1K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
The first energy-releasing step—the 6th step of glycolysis...
147.1K
Bacterial Signaling
41.2K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
41.2K
Yeast Signaling
17.3K
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.3K
Synaptic Signaling
79.8K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.8K


